Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Old API Wind-down Ltd - Ordinary Shares ARLZQ

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently... see more

Recent & Breaking News (OTCPK:ARLZQ)

Aralez Announces National U.S. Commercial Launch Of Zontivity

PR Newswire June 7, 2017

Biotech Stocks on Investors' Radar -- Achillion Pharma, Acorda Therapeutics, Aralez Pharma, and Regulus Therapeutics

PR Newswire May 26, 2017

Aralez to present at the Jefferies Healthcare Conference

PR Newswire May 23, 2017

Investor Network: Aralez Pharmaceuticals Inc. to Host Earnings Call

Accesswire May 9, 2017

Aralez Reports First Quarter 2017 Financial Results

PR Newswire May 9, 2017

Aralez Announces Voting Results From 2017 Annual And Special Meeting Of Shareholders

PR Newswire May 3, 2017

Aralez To Report First Quarter 2017 Financial Results On May 9, 2017

PR Newswire April 25, 2017

Aralez Announces Reduction In U.S. Sales Force And Cost Savings Program

PR Newswire April 5, 2017

Biotech Stocks on Investors' Radar -- Editas, Intra-Cellular, Aralez Pharma, and Catabasis Pharma

PR Newswire March 21, 2017

12 Biggest Mid-Day Gainers For Monday

Benzinga.com  March 20, 2017

Aralez CEO Purchases 500,000 Shares Of Company Common Stock On Open Market

PR Newswire March 20, 2017

Mid-Afternoon Market Update: Nobilis Health Drops After Q4 Results; Heat Biologics Shares Spike HIgher

Benzinga.com  March 13, 2017

12 Biggest Mid-Day Losers For Monday

Benzinga.com  March 13, 2017

Mid-Day Market Update: AMEC Foster Wheeler Surges Following Wood Group Bid; Aralez Pharmaceuticals Shares Plunge

Benzinga.com  March 13, 2017

Aralez Reports Fourth Quarter And Full-Year 2016 Financial Results

PR Newswire March 13, 2017

Earnings Scheduled For March 13, 2017

Benzinga.com  March 13, 2017

Aralez To Announce Fourth Quarter And Full-Year 2016 Results On March 13, 2017

PR Newswire February 27, 2017

Aralez to Present at the RBC Capital Markets Global Healthcare Conference

PR Newswire February 16, 2017

Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ) to Ring The Nasdaq Stock Market Closing Bell

GlobeNewswire February 13, 2017

Aralez To Ring Closing Bell At Nasdaq On February 14, 2017

PR Newswire February 13, 2017